Press Releases
Starving Tuberculosis (TB) of sugars may be a new way to fight it
Tuberculosis is a devastating disease that claims over 1.5 million lives each year. The increase in TB cases that are resistant to the current antibiotics means that novel drugs to kill Mycobacterium tuberculosis (Mtb) are urgently needed. Researchers from the University of Warwick have successfully discovered how Mycobacterium tuberculosis uses an essential sugar called trehalose, which provides a platform to design new and improved TB drugs and diagnostic agents.
Construction completed on “world-class” IBRB biomedical research building at the University of Warwick
NATIONAL contractor, Willmott Dixon has completed the construction of the Interdisciplinary Biomedical Research Building at the University of Warwick this month (March 2021).
How bacterial traffic jams lead to antibiotic-resistant, multilayer biofilms
New insight on the physical interactions that take place between swarming bacteria when exposed to antibiotics could lead to novel approaches for treating infections in patients.
Tales of Treatment highlight the benefits of grassroots public engagement for researchers
An approach to public engagement which respects grass-roots and community knowledge has an important role to play in improving our understanding of the relationship between traditional healing and Western-style medicine in low and middle-income countries, and could generate new approaches to tackling antimicrobial resistance, according to a new paper published in Medical Humanities.
Medieval medicine remedy could provide new treatment for modern day infections
Antibiotic resistance is an increasing battle for scientists to overcome, as more antimicrobials are urgently needed to treat biofilm-associated infections. However scientists from the School of Life Sciences at the University of Warwick say research into natural antimicrobials could provide candidates to fill the antibiotic discovery gap.
Breakthrough in understanding enzymes that make antibiotic for drug-resistant pathogen
One of the WHO’s three critical priority pathogens, Acinetobacter baumannii, for which new antibiotics are urgently needed is one step closer to being tackled, as researchers from the Department of Chemistry - University of Warwick have made a breakthrough in understanding the enzymes that assemble the antibiotic enacyloxin.